Reaction
Embolia Cutis Medicamentosa reporting signals
As of the last recalculation, Embolia Cutis Medicamentosa appears in 791 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is DICLOFENAC (PRR 186.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Diclofenac | 345 | 186.1 | 186.9 |
| Diclofenac Sodium 1% | 127 | 111.2 | 111.6 |
| Diclofenac Sodium Topical | 127 | 111.2 | 111.6 |
| Diclofenac Sodium Topical Gel, 1% | 127 | 111.0 | 111.4 |
| Diclofenac Sodium | 351 | 109.5 | 109.8 |
| Diclofenac Potassium, Film Coated | 17 | 54.3 | 54.4 |
| Diclofenac Potassium Tablets | 17 | 54.3 | 54.4 |
| Glatiramer Acetate | 87 | 42.9 | 43.0 |
| Diclofenac Potassium | 17 | 42.3 | 42.3 |
| Naltrexone | 9 | 7.8 | 7.8 |